Miocamycin is a macrolide antibiotic. It has a spectrum activity similar to that of Erythromycin, but shows higher ... In-vivo studies have further expounded on Miocamycins efficacy, reporting that the medication is more effective than in-vitro ... Lyseng-Williamson, Katherine A (June 2006). "Miocamycin is an effective option in the treatment of various bacterial infections ... Holliday SM, Faulds D (October 1993). "Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and ...
miocamycin 1.2 g O J01FA12 rokitamycin 0.8 g O J01FA13 dirithromycin 0.5 g O ...
Miocamycin Miocamycin is a macrolide antibiotic of Streptomyces origin that inhibits protein synthesis by binding to the ...
Miocamycin Susc Islt 3 LOINC_Long_Common_Name LOINC Long Common Name Miocamycin [Susceptibility] ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
Lagos R, et al, Benzathine penicillin G and miocamycin in the treatment of children with streptococcal pharyngitis: a ...
Per The ICU Book "The first rule of antibiotics is to try not to use them, and the second rule is try not to use too many of them."[80] Inappropriate antibiotic treatment and overuse of antibiotics have contributed to the emergence of antibiotic-resistant bacteria. Self-prescribing of antibiotics is an example of misuse.[81] Many antibiotics are frequently prescribed to treat symptoms or diseases that do not respond to antibiotics or that are likely to resolve without treatment. Also, incorrect or suboptimal antibiotics are prescribed for certain bacterial infections.[23][81] The overuse of antibiotics, like penicillin and erythromycin, has been associated with emerging antibiotic resistance since the 1950s.[63][82] Widespread usage of antibiotics in hospitals has also been associated with increases in bacterial strains and species that no longer respond to treatment with the most common antibiotics.[82] Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in ...
This graph shows the total number of publications written about "Lucensomycin" by people in UAMS Profiles by year, and whether "Lucensomycin" was a major or minor topic of these publications ...
Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an antiprotozoal agent, and in the treatment of BENIGN PROSTATIC HYPERTROPHY ...
Xiao L, Ratliff AE, Crabb DM, Mixon E, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy LB, Fowler KB, Atkinson TP, Waites KB. Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018. J Clin Microbiol. 2020 09 22; 58(10 ...
J01FA11: miocamicina - miocamycin *J01FA12: rokitamicina - rokitamycin *J01FA13: diritromicina - dirithromycin *J01FA14: ...
Miocamycin [D02.540.505.500] * Natamycin [D02.540.505.550] * Nystatin [D02.540.505.575] * Oleandomycin [D02.540.505.600] ...
miocamycin 1.2 g O J01FA12 rokitamycin 0.8 g O J01FA13 dirithromycin 0.5 g O ...
DNA methylation in PFs is a possible marker detecting occult neoplastic cells on the peritoneum. Methylation analysis along with a cytological examination might therefore improve the positive detection of cancer cells in PF of gastric cancer.
... miocamycin; ponsinomycin), josamycin and roxithromycin (group 2) rarely cause interactions. Azithromycin, dirithromycin, ...
Miocamycin - Preferred Concept UI. M0023981. Scope note. A macrolide antibiotic that has a wide antimicrobial spectrum and is ... Miocamycin Entry term(s). 9,3 Di O Acetylmidecamycin 9,3 Diacetylmidecamycin 9,3-Di-O-Acetylmidecamycin 9,3- ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
Miocamycin Preferred Term Term UI T046260. Date01/01/1999. LexicalTag NON. ThesaurusID ... Miocamycin Preferred Concept UI. M0023981. Registry Number. 3T48CPS7U2. Related Numbers. 55881-07-7. Scope Note. A macrolide ... Miocamycin. Tree Number(s). D02.540.505.500. Unique ID. D015644. RDF Unique Identifier. http://id.nlm.nih.gov/mesh/D015644 ...
Miocamycin Preferred Term Term UI T046260. Date01/01/1999. LexicalTag NON. ThesaurusID ... Miocamycin Preferred Concept UI. M0023981. Registry Number. 3T48CPS7U2. Related Numbers. 55881-07-7. Scope Note. A macrolide ... Miocamycin. Tree Number(s). D02.540.505.500. Unique ID. D015644. RDF Unique Identifier. http://id.nlm.nih.gov/mesh/D015644 ...
Kinetic Profile of Miocamycin in Middle Ear Fluid and Mucosa *. Acta Oto-Laryngologica ...
Histocompatibility Antigens N0000171194 Minor Lymphocyte Stimulatory Antigens N0000007452 Minoxidil N0000168430 Miocamycin ...
... miocamycin, rokitamycin, andazithromycin, and swinolide A; fluoroquinolones such as ciprofloxacin, ofloxacin, levofloxacin, ...
ANTI-INFECTIVE AGENTS MIOCAMYCIN ANTI-INFECTIVE AGENTS MISONIDAZOLE ANTI-INFECTIVE AGENTS MITOMYCIN ANTI-INFECTIVE AGENTS ... ANTIBIOTICS MIOCAMYCIN ANTIBIOTICS MITOMYCIN ANTIBIOTICS MITOMYCINS ANTIBIOTICS MONOBACTAMS ANTIBIOTICS MOXALACTAM ANTIBIOTICS ... MACROLIDE MIOCAMYCIN ANTIBIOTICS, MACROLIDE NATAMYCIN ANTIBIOTICS, MACROLIDE NYSTATIN ANTIBIOTICS, MACROLIDE OLEANDOMYCIN ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
D1.650.550.925.600 Miocamycin D4.345.349.500 D9.408.477.500 Mitochondrial ADP, ATP Translocases D12.776.543.585.475.500 ...
A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties ...
Miocamycin [D02.540.505.500] * Natamycin [D02.540.505.550] * Nystatin [D02.540.505.575] * Oleandomycin [D02.540.505.600] ...